{"disease":{"id":"impulse-control-disorder","name":"impulse control disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07505394","title":"Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":528,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05712057","title":"Neurostimulation Versus Therapy for Problems With Emotions","phase":"NA","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT02722174","title":"Fingerprinting of Impulsivity","phase":"","overall_status":"COMPLETED","enrollment_count":141,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT03146130","title":"Study of the Efficacy of N-acetylcysteine (NAC) on Impulse Control Disorders","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT06561919","title":"STIMPulseControl Ancillary Speech Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Steffen Paschen","has_results":false},{"nct_id":"NCT06498349","title":"Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"University of Kiel","has_results":false},{"nct_id":"NCT02755181","title":"fMRI in Impulsivity","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT03970239","title":"Serotonin in Impulse Control Disorders in Parkinson's Disease","phase":"NA","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03887429","title":"Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Promentis Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT06639594","title":"Feasibility of Accelerated, Personalized rTMS as an Adjuvant for Impulse Control Disorders: a Pilot Study","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT06485986","title":"Frontosubthalamic Networks in Parkinson's Disease.","phase":"NA","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"University of Oxford","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}